Katherine A. Overmyer

Katherine A. Overmyer

Auto-generated profile, based on publicly available information

Katherine A. Overmyer

Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Cell Systems
Verified
Journal Article
Open access
KOKatherine A. Overmyer
Katherine A. Overmyer
ESEvgenia Shishkova
Evgenia Shishkova
IMIan J. Miller
Ian J. Miller
JBJoseph Balnis
Joseph Balnis
MBMatthew N. Bernstein
Matthew N. Bernstein
AJAriel Jaitovich
Ariel Jaitovich
We performed RNA-seq and high-resolution mass spectrometry on 128 blood samples from COVID-19-positive and COVID-19-negative patients with diverse disease severities and outcomes. Quantified transcripts, proteins, metabolites, and lipids were associated with clinical outcomes in a curated relational database, uniquely enabling systems analysis and cross-ome correlations to molecules and patient prognoses. We mapped 219 molecular features with high significance to COVID-19 status and severity, many of which were involved in complement activation, dysregulated lipid transport, and neutrophil activation. We identified sets of covarying molecules, e.g., protein gelsolin and metabolite citrate or plasmalogens and apolipoproteins, offering pathophysiological insights and therapeutic suggestions. The observed dysregulation of platelet function, blood coagulation, acute phase response, and endotheliopathy further illuminated the unique COVID-19 phenotype. We present a web-based tool (covid-omics.app) enabling interactive exploration of our compendium and illustrate its utility through a machine learning approach for prediction of COVID-19 severity.

25 May 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JRJarred W. Rensvold
Jarred W. Rensvold
ESEvgenia Shishkova
Evgenia Shishkova
YSYuriy Sverchkov
Yuriy Sverchkov
IMIan J. Miller
Ian J. Miller
ACArda Cetinkaya
Arda Cetinkaya
DPDavid J. Pagliarini
David J. Pagliarini

14 May 2025 in Journal of Proteome Research
Verified
Journal Article
Open access
WBWilliam F. Beimers
William F. Beimers
KOKatherine A. Overmyer
Katherine A. Overmyer
PSPavel Sinitcyn
Pavel Sinitcyn
NLNoah M. Lancaster
Noah M. Lancaster
SQScott T. Quarmby
Scott T. Quarmby
JCJoshua J. Coon
Joshua J. Coon
Plasma proteomics technologies are rapidly evolving and of critical importance to the field of biomedical research. Here, we report a technical evaluation of six notable plasma proteomics technologies─unenriched (Neat), acid depletion, PreOmics ENRICHplus, Mag-Net, Seer Proteograph XT, and Olink Explore HT. The methods were compared on proteomic depth, reproducibility, linearity, tolerance to lipid interference, and limit of detection/quantification. In total, we performed 618 LC-MS/MS experiments and 93 Olink Explore HT assays. The Seer method achieved the greatest proteomic depth (∼4500 proteins detected), while Olink detected ∼2600 proteins. Other MS-based methods ranged from ∼500-2200 proteins detected. In our analysis, Neat, Mag-Net, Seer, and Olink had good reproducibility, while PreOmics and Acid had higher variability (>20% median coefficient of variation). All MS methods showed good linearity with spiked-in C-reactive protein (CRP); CRP was surprisingly not in the Olink assay. None of the methods were affected by lipid interference. Seer produced the highest number of quantifiable proteins with a measurable LOD (4407) and LOQ (2696). Olink had the next highest number of quantifiable proteins, with 2002 having an LOD and 1883 having an LOQ. Finally, we tested the applicability of these methods for detecting differences between healthy and cancer groups in a nonsmall cell lung cancer (NSCLC) cohort. All six methods detected differentially abundant proteins between the cancer and healthy samples but disagreed on which proteins were significant, highlighting the contrast between each method.

19 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
NNNatalie Niemi
Natalie Niemi
GWGary M. Wilson
Gary M. Wilson
KOKatherine A. Overmyer
Katherine A. Overmyer
FVF.-Nora Vögtle
F.-Nora Vögtle
LMLisa Myketin
Lisa Myketin
DPDavid J. Pagliarini
David J. Pagliarini
Mitochondrial proteins are replete with phosphorylation, yet its functional relevance remains largely unclear. The presence of multiple resident mitochondrial phosphatases, however, suggests that protein dephosphorylation may be broadly important for calibrating mitochondrial activities. To explore this, we deleted the poorly characterized matrix phosphatase Pptc7 from mice using CRISPR-Cas9 technology. Strikingly, Pptc7−/− mice exhibit hypoketotic hypoglycemia, elevated acylcarnitines and serum lactate, and die soon after birth. Pptc7−/− tissues have markedly diminished mitochondrial size and protein content despite normal transcript levels, and aberrantly elevated phosphorylation on select mitochondrial proteins. Among these, we identify the protein translocase complex subunit Timm50 as a putative Pptc7 substrate whose phosphorylation reduces import activity. We further find that phosphorylation within or near the mitochondrial targeting sequences of multiple proteins could disrupt their import rates and matrix processing. Overall, our data define Pptc7 as a protein phosphatase essential for proper mitochondrial function and biogenesis during the extrauterine transition.

16 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
HPHankum Park
Hankum Park
FHFrances V. Hundley
Frances V. Hundley
QYQing Yu
Qing Yu
KOKatherine A. Overmyer
Katherine A. Overmyer
DBDain R. Brademan
Dain R. Brademan
JHJ. Wade Harper
J. Wade Harper
Degradation and recycling of plasma membrane proteins occurs via the endolysosomal system, wherein endosomes bud into the cytosol from the plasma membrane and subsequently mature into degradative lysosomal compartments. While methods have been developed for rapid selective capture of lysosomes (Lyso-IP), analogous methods for isolation of early endosome intermediates are lacking. Here, we develop an approach for rapid isolation of early/sorting endosomes through affinity capture of the early endosome-associated protein EEA1 (Endo-IP) and provide proteomic and lipidomic snapshots of EEA1-positive endosomes in action. We identify recycling, regulatory and membrane fusion complexes, as well as candidate cargo, providing a proteomic landscape of early/sorting endosomes. To demonstrate the utility of the method, we combined Endo- and Lyso-IP with multiplexed targeted proteomics to provide a spatial digital snapshot of amyloid precursor protein (APP) processing by β and γ-Secretases, which produce amyloidogenic Aβ species, and quantify small molecule modulation of Secretase action on endosomes. We anticipate that the Endo-IP approach will facilitate systematic interrogation of processes that are coordinated on EEA1-positive endosomes.

21 September 2020 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
VLVanessa Linke
Vanessa Linke
KOKatherine A. Overmyer
Katherine A. Overmyer
IMIan J. Miller
Ian J. Miller
DBDain R. Brademan
Dain R. Brademan
PHPaul D. Hutchins
Paul D. Hutchins
JCJoshua J. Coon
Joshua J. Coon